Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury

Free Radical Biology and Medicine

Volumn 52, Issue 8, 2012, Pages 1382-1402

  Van Golen, Rowan F ^a   Van Gulik, Thomas M ^a   Heger, Michal ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Damage associated molecular patterns; Free radicals; Liver pathology; Microcirculation; Oxidative and nitrosative stress; Sterile inflammation

Indexed keywords

CARBONIC ACID; CHONDROITIN SULFATE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; HYDROXYL RADICAL; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SIALIC ACID; XANTHINE OXIDASE;

BIOCHEMISTRY; CELL FUNCTION; DISEASE MODEL; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLYCOCALYX; KUPFFER CELL; LIVER ISCHEMIA; LIVER STRUCTURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; THROMBOCYTE;

ANIMALS; GLYCOCALYX; HUMANS; LIVER; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 84859008844     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.01.013     Document Type: Review

References (335)

1. Pringle, J. H. V. Notes on the arrest of hepatic hemorrhage due to trauma. Ann. Surg. 48:541-549; 1908.
2. Clavien, P. A.; Petrowsky, H.; DeOliveira, M. L.; Graf, R. Strategies for safer liver surgery and partial liver transplantation. N. Engl. J. Med. 356:1545-1559; 2007.
3. Man, K.; Fan, S. T.; Ng, I. O.; Lo, C. M.; Liu, C. L.; Wong, J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann. Surg. 226:704-711 discussion 711-713; 1997.
4. Gurusamy, K. S.; Kumar, Y.; Ramamoorthy, R.; Sharma, D.; Davidson, B. R. Vascular occlusion for elective liver resections. Cochrane Database Syst. Rev. CD007530; 2009.
5. Rubio-Gayosso, I.; Platts, S. H.; Duling, B. R. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 290:H2247-H2256; 2006.
6. Murai, T.; Sougawa, N.; Kawashima, H.; Yamaguchi, K.; Miyasaka, M. CD44-chondroitin sulfate interactions mediate leukocyte rolling under physiological flow conditions. Immunol. Lett. 93:163-170; 2004.
7. Stanford, K. I.; Bishop, J. R.; Foley, E. M.; Gonzales, J. C.; Niesman, I. R.; Witztum, J. L.; Esko, J. D. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J. Clin. Invest. 119:3236-3245; 2009.
8. McDonald, B.; McAvoy, E. F.; Lam, F.; Gill, V.; de la Motte, C.; Savani, R. C.; Kubes, P. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med. 205:915-927; 2008.
9. Van Teeffelen, J. W.; Brands, J.; Stroes, E. S.; Vink, H. Endothelial glycocalyx: sweet shield of blood vessels. Trends Cardiovasc. Med. 17:101-105; 2007.
10. Weinbaum, S.; Tarbell, J. M.; Damiano, E. R. The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 9:121-167; 2007.
11. Vollmar, B.; Menger, M. D. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol. Rev. 89: 1269-1339; 2009.
12. Rappaport, A. M. Hepatic blood flow: morphologic aspects and physiologic regulation. Int. Rev. Physiol. 21:1-63; 1980.
13. Wisse, E.; De Zanger, R. B.; Charels, K.; Van Der Smissen, P.; McCuskey, R. S. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 5:683-692; 1985.
14. Suematsu, M.; Wakabayashi, Y.; Ishimura, Y. Gaseous monoxides: a new class of microvascular regulator in the liver. Cardiovasc. Res. 32:679-686; 1996.
15. Yokoyama, Y.; Nimura, Y.; Nagino, M.; Bland, K. I.; Chaudry, I. H. Role of thromboxane in producing hepatic injury during hepatic stress. Arch. Surg. 140:801-807; 2005.
16. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; Mencarelli, A.; Orlandi, S.; Zanardo, R.; Renga, B.; Di Sante, M.; Morelli, A.; Cirino, G.; Wallace, J. L. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by antiinflammatory nonsteroidal drugs. Gastroenterology 129:1210-1224; 2005.
17. Rensing, H.; Bauer, I.; Zhang, J. X.; Paxian, M.; Pannen, B. H. J.; Yokoyama, Y.; Clemens, M. G.; Bauer, M. Endothelin-1 and heme oxygenase-1 as modulators of sinusoidal tone in the stress-exposed rat liver. Hepatology 36:1453-1465; 2002.
18. Pannen, B. H. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth. Analg. 94:1448-1457; 2002.
19. Smedsrød, B.; De Bleser, P. J.; Braet, F.; Lovisetti, P.; Vanderkerken, K.; Wisse, E.; Geerts, A. Cell biology of liver endothelial and Kupffer cells. Gut 35:1509-1516; 1994.
20. Crispe, I. N. The liver as a lymphoid organ. Annu. Rev. Immunol. 27:147-163; 2009.
21. Bamboat, Z. M.; Ocuin, L. M.; Balachandran, V. P.; Obaid, H.; Plitas, G.; Dematteo, R. P. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J. Clin. Invest. 120:559-569; 2010.
22. Jaeschke, H.; Farhood, A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 260:G355-G362; 1991.
23. Jaeschke, H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G1083-G1088; 2006.
24. Vink, H.; Duling, B. R. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ. Res. 79: 581-589; 1996.
25. Smith, M. L.; Long, D. S.; Damiano, E. R.; Ley, K. Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys. J. 85:637-645; 2003.
26. Potter, D. R.; Damiano, E. R. The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ. Res. 102:770-776; 2008.
27. Reitsma, S.; Slaaf, D. W.; Vink, H.; van Zandvoort, M. A.; oude Egbrink, M. G. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 454:345-359; 2007.
28. De Cat, B.; Muyldermans, S. Y.; Coomans, C.; Degeest, G.; Vanderschueren, B.; Creemers, J.; Biemar, F.; Peers, B.; David, G. Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements. J. Cell Biol. 163:625-635; 2003.
29. Rosenberg, R. D.; Shworak, N. W.; Liu, J.; Schwartz, J. J.; Zhang, L. Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J. Clin. Invest. 99:2062-2070; 1997.
30. Saunders, S.; Jalkanen, M.; O'Farrell, S.; Bernfield, M.Molecular cloning of syndecan, an integral membrane proteoglycan. J. Cell Biol. 108:1547-1556; 1989.
31. David, G.; Lories, V.; Decock, B.; Marynen, P.; Cassiman, J. J.; Van den Berghe, H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J. Cell Biol. 111:3165-3176; 1990.
32. Kokenyesi, R.; Bernfield, M. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. J. Biol. Chem. 269:12304-12309; 1994.
33. Chen, R. L.; Lander, A. D. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J. Biol. Chem. 276:7507-7517; 2001.
34. Zhang, L.; David, G.; Esko, J. D. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. J. Biol. Chem. 270:27127-27135; 1995.
35. Esko, J. D.; Zhang, L. Influence of core protein sequence on glycosaminoglycan assembly. Curr. Opin. Struct. Biol. 6:663-670; 1996.
36. Aikawa, J.; Grobe, K.; Tsujimoto, M.; Esko, J. D. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase: structure and activity of the fourth member, NDST4. J. Biol. Chem. 276:5876-5882; 2001.
37. Kjellén, L.; Lindahl, U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:443-475; 1991.
38. Li, J. P.; Gong, F.; Hagner-McWhirter, A.; Forsberg, E.; Abrink, M.; Kisilevsky, R.; Zhang, X.; Lindahl, U. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J. Biol. Chem. 278:28363-28366; 2003.
39. Kusche-Gullberg, M.; Kjellén, L. Sulfotransferases in glycosaminoglycan biosynthesis. Curr. Opin. Struct. Biol. 13:605-611; 2003.
40. Esko, J. D.; Selleck, S. B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71:435-471; 2002.
41. Esko, J. D.; Lindahl, U. Molecular diversity of heparan sulfate. J. Clin. Invest. 108: 169-173; 2001.
42. Toida, T.; Yoshida, H.; Toyoda, H.; Koshiishi, I.; Imanari, T.; Hileman, R. E.; Fromm, J. R.; Linhardt, R. J. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem. J. 322 (Pt 2):499-506; 1997.
43. Lapcík Jr., L.; Lapcík, L.; De Smedt, S.; Demeester, J.; Chabrecek, P. Hyaluronan: preparation, structure, properties, and applications. Chem. Rev. 98:2663-2684; 1998.
44. Laurent, T. C.; Fraser, J. R. Hyaluronan. FASEB J. 6:2397-2404; 1992.
45. Culty, M.; Miyake, K.; Kincade, P. W.; Sikorski, E.; Butcher, E. C.; Underhill, C.; Silorski, E. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol. 111:2765-2774; 1990.
46. Savani, R. C.; Cao, G.; Pooler, P. M.; Zaman, A.; Zhou, Z.; DeLisser, H. M. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HAmediated motility in endothelial cell function and angiogenesis. J. Biol. Chem. 276:36770-36778; 2001.
47. Turley, E. A.; Roth, S. Interactions between the carbohydrate chains of hyaluronate and chondroitin sulphate. Nature 283:268-271; 1980.
48. Roskams, T.; Moshage, H.; De Vos, R.; Guido, D.; Yap, P.; Desmet, V. Heparan sulfate proteoglycan expression in normal human liver. Hepatology 21: 950-958; 1995.
49. McDonald, B.; Pittman, K.; Menezes, G. B.; Hirota, S. A.; Slaba, I.; Waterhouse, C. C.; Beck, P. L.; Muruve, D. A.; Kubes, P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362-366; 2010.
50. Khandoga, A.; Biberthaler, P.; Enders, G.; Axmann, S.; Hutter, J.; Messmer, K.; Krombach, F. Platelet adhesion mediated by fibrinogen-intercellular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo. Transplantation 74:681-688; 2002.
51. Staunton, D. E.; Dustin, M. L.; Erickson, H. P.; Springer, T. A. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 61:243-254; 1990.
52. Mulivor, A. W.; Lipowsky, H. H. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am. J. Physiol. Heart Circ. Physiol. 283:H1282-H1291; 2002.
53. Mulivor, A. W.; Lipowsky, H. H. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 286:H1672-H1680; 2004.
54. Vink, H.; Constantinescu, A. A.; Spaan, J. A. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101:1500-1502; 2000.
55. Nieuwdorp, M.; Meuwese, M. C.; Vink, H.; Hoekstra, J. B.; Kastelein, J. J.; Stroes, E. S. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr. Opin. Lipidol. 16:507-511; 2005.
56. Henry, C. B.; Duling, B. R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Physiol. 277:H508-H514; 1999.
57. van den Berg, B. M.; Vink, H.; Spaan, J. A. The endothelial glycocalyx protects against myocardial edema. Circ. Res. 92:592-594; 2003.
58. Levick, J. R.; Michel, C. C. Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87:198-210; 2010.
59. Curry, F. R.; Adamson, R. H. Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. Cardiovasc. Res. 87:218-229; 2010.
60. Chappell, D.; Jacob, M.; Hofmann-Kiefer, K.; Bruegger, D.; Rehm, M.; Conzen, P.; Welsch, U.; Becker, B. F. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 107:776-784; 2007.
61. Ott, I.;Miyagi, Y.; Miyazaki, K.; Heeb, M. J.; Mueller, B. M.; Rao, L. V.; Ruf, W. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositolanchored tissue factor pathway inhibitor. Arterioscler. Thromb. Vasc. Biol. 20: 874-882; 2000.
62. Dunzendorfer, S.; Kaneider, N.; Rabensteiner, A.; Meierhofer, C.; Reinisch, C.; Römisch, J.; Wiedermann, C. J. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 97:1079-1085; 2001.
63. Chappell, D.; Jacob, M.; Hofmann-Kiefer, K.; Rehm, M.; Welsch, U.; Conzen, P.; Becker, B. F. Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc. Res. 83:388-396; 2009.
64. Nieuwdorp, M.; van Haeften, T. W.; Gouverneur, M. C.; Mooij, H. L.; van Lieshout, M. H.; Levi, M.; Meijers, J. C.; Holleman, F.; Hoekstra, J. B.; Vink, H.; Kastelein, J. J.; Stroes, E. S. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55: 480-486; 2006.
65. López-Casillas, F.; Wrana, J. L.; Massagué, J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73:1435-1444; 1993.
66. Wilsie, L. C.; Orlando, R. A. The lowdensity lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J. Biol. Chem. 278:15758-15764; 2003.
67. Tkachenko, E.; Rhodes, J. M.; Simons, M. Syndecans: new kids on the signaling block. Circ. Res. 96:488-500; 2005.
68. Thi, M. M.; Tarbell, J. M.; Weinbaum, S.; Spray, D. C. The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a "bumper-car"model. Proc. Natl. Acad. Sci. U. S. A. 101:16483-16488; 2004.
69. Florian, J. A.; Kosky, J. R.; Ainslie, K.; Pang, Z.; Dull, R. O.; Tarbell, J. M. Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ. Res. 93: e136-e142; 2003.
70. Tarbell, J. M. Shear stress and the endothelial transport barrier. Cardiovasc. Res. 87:320-330; 2010.
71. Jaeschke, H.; Bautista, A. P.; Spolarics, Z.; Spitzer, J. J. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J. Leukoc. Biol. 52:377-382; 1992.
72. Turrens, J. F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552: 335-344; 2003.
73. Cadenas, E.; Boveris, A.; Ragan, C. I.; Stoppani, A. O. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinolcytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 180:248-257; 1977.
74. Horie, Y.; Wolf, R.; Anderson, D. C.; Granger, D. N. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion. J. Clin. Invest. 99:781-788; 1997.
75. Jaeschke, H.; Mitchell, J. R. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem. Biophys. Res. Commun. 160:140-147; 1989.
76. Caraceni, P.; Ryu, H. S.; van Thiel, D. H.; Borle, A. B. Source of oxygen free radicals produced by rat hepatocytes during postanoxic reoxygenation. Biochim. Biophys. Acta 1268:249-254; 1995.
77. Shiva, S.; Sack, M. N.; Greer, J. J.; Duranski, M.; Ringwood, L. A.; Burwell, L.; Wang, X.; MacArthur, P. H.; Shoja, A.; Raghavachari, N.; Calvert, J. W.; Brookes, P. S.; Lefer, D. J.; Gladwin, M. T. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med. 204: 2089-2102; 2007.
78. Wang, W.; Fang, H.; Groom, L.; Cheng, A.; Zhang, W.; Liu, J.; Wang, X.; Li, K.; Han, P.; Zheng, M.; Yin, J.; Wang, W.; Mattson, M. P.; Kao, J. P.; Lakatta, E. G.; Sheu, S. S.; Ouyang, K.; Chen, J.; Dirksen, R. T.; Cheng, H. Superoxide flashes in single mitochondria. Cell 134:279-290; 2008.
79. Turrens, J. F.; Freeman, B. A.; Levitt, J. G.; Crapo, J. D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys. 217:401-410; 1982.
80. Poyton, R. O.; Ball, K. A.; Castello, P. R. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol. Metab. 20:332-340; 2009.
81. Castello, P. R.; David, P. S.; McClure, T.; Crook, Z.; Poyton, R. O. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab. 3:277-287; 2006.
82. Castello, P. R.; Woo, D. K.; Ball, K.; Wojcik, J.; Liu, L.; Poyton, R. O. Oxygen-regulated isoforms of cytochrome c oxidase have differential effects on its nitric oxide production and on hypoxic signaling. Proc. Natl. Acad. Sci. U. S. A. 105: 8203-8208; 2008.
83. Lancaster, J. R. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 91:8137-8141; 1994.
84. Ghafourifar, P.; Cadenas, E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 26:190-195; 2005.
85. Pearce, L. L.; Epperly, M. W.; Greenberger, J. S.; Pitt, B. R.; Peterson, J. Identification of respiratory complexes I and III as mitochondrial sites of damage following exposure to ionizing radiation and nitric oxide. Nitric Oxide 5:128-136; 2001.
86. Radi, R.; Rodriguez, M.; Castro, L.; Telleri, R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308:89-95; 1994.
87. Borutaite, V.; Budriunaite, A.; Brown, G. C. Reversal of nitric oxide-, peroxynitriteand S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim. Biophys. Acta 1459:405-412; 2000.
88. Radi, R.; Cassina, A.; Hodara, R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol. Chem. 383:401-409; 2002.
89. Henderson, J. R.; Swalwell, H.; Boulton, S.; Manning, P.; McNeil, C. J.; Birch-Machin, M. A. Direct, real-time monitoring of superoxide generation in isolated mitochondria. Free. Radic. Res. 43:796-802; 2009.
90. Dirmeier, R.; O'Brien, K. M.; Engle, M.; Dodd, A.; Spears, E.; Poyton, R. O. Exposure of yeast cells to anoxia induces transient oxidative stress: implications for the induction of hypoxic genes. J. Biol. Chem. 277:34773-34784; 2002.
91. Guidarelli, A.; Sciorati, C.; Clementi, E.; Cantoni, O. Peroxynitritemobilizes calcium ions from ryanodine-sensitive stores, a process associated with the mitochondrial accumulation of the cation and the enforced formation of species mediating cleavage of genomic DNA. Free Radic. Biol. Med. 41:154-164; 2006.
92. Guidarelli, A.; Tommasini, I.; Fiorani, M.; Cantoni, O. Essential role of the mitochondrial respiratory chain in peroxynitrite-induced strand scission of genomic DNA. IUBMB Life 50:195-201; 2000.
93. Redondo-Horcajo, M.; Romero, N.; Martínez-Acedo, P.; Martínez-Ruiz, A.; Quijano, C.; Lourenço, C. F.; Movilla, N.; Enríquez, J. A.; Rodríguez-Pascual, F.; Rial, E.; Radi, R.; Vázquez, J.; Lamas, S. Cyclosporine A-induced nitration of tyrosine 34 MnSOD in endothelial cells: role of mitochondrial superoxide. Cardiovasc. Res. 87:356-365; 2010.
94. Baines, C. P.; Kaiser, R. A.; Purcell, N. H.; Blair, N. S.; Osinska, H.; Hambleton, M. A.; Brunskill, E. W.; Sayen, M. R.; Gottlieb, R. A.; Dorn, G. W.; Robbins, J.; Molkentin, J. D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658-662; 2005.
95. Vieira, H. L.; Belzacq, A. S.; Haouzi, D.; Bernassola, F.; Cohen, I.; Jacotot, E.; Ferri, K. F.; El Hamel, C.; Bartle, L. M.; Melino, G.; Brenner, C.; Goldmacher, V.; Kroemer, G. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20:4305-4316; 2001.
96. Halestrap, A. Biochemistry: a pore way to die. Nature 434:578-579; 2005.
97. Jaeschke, H.; Lemasters, J. J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125:1246-1257; 2003.
98. Kohli, V.; Selzner, M.; Madden, J. F.; Bentley, R. C.; Clavien, P. A. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 67:1099-1105; 1999.
99. Gujral, J. S.; Bucci, T. J.; Farhood, A.; Jaeschke, H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 33:397-405; 2001.
100. Bradford, B. U.; Marotto, M.; Lemasters, J. J.; Thurman, R. G. New, simple models to evaluate zone-specific damage due to hypoxia in the perfused rat liver: time course and effect of nutritional state. J. Pharmacol. Exp. Ther. 236:263-268; 1986.
101. Kono, H.; Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8:279-289; 2008.
102. Tsung, A.; Klune, J. R.; Zhang, X.; Jeyabalan, G.; Cao, Z.; Peng, X.; Stolz, D. B.; Geller, D. A.; Rosengart, M. R.; Billiar, T. R. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 204:2913-2923; 2007.
103. Zhang, Q.; Raoof, M.; Chen, Y.; Sumi, Y.; Sursal, T.; Junger, W.; Brohi, K.; Itagaki, K.; Hauser, C. J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104-107; 2010.
104. Tian, J.; Avalos, A. M.; Mao, S. Y.; Chen, B.; Senthil, K.; Wu, H.; Parroche, P.; Drabic, S.; Golenbock, D.; Sirois, C.; Hua, J.; An, L. L.; Audoly, L.; La Rosa, G.; Bierhaus, A.; Naworth, P.; Marshak-Rothstein, A.; Crow, M. K.; Fitzgerald, K. A.; Latz, E.; Kiener, P. A.; Coyle, A. J. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8:487-496; 2007.
105. Elliott, M. R.; Chekeni, F. B.; Trampont, P. C.; Lazarowski, E. R.; Kadl, A.; Walk, S. F.; Park, D.; Woodson, R. I.; Ostankovich, M.; Sharma, P.; Lysiak, J. J.; Harden, T. K.; Leitinger, N.; Ravichandran, K. S. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282-286; 2009.
106. Zhang, M.; Alicot, E. M.; Chiu, I.; Li, J.; Verna, N.; Vorup-Jensen, T.; Kessler, B.; Shimaoka, M.; Chan, R.; Friend, D.; Mahmood, U.; Weissleder, R.; Moore, F. D.; Carroll, M. C. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203:141-152; 2006.
107. Diepenhorst, G. M.; van Gulik, T. M.; Hack, C. E. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann. Surg. 249:889-899; 2009.
108. Zhai, Y.; Shen, X. D.; O'Connell, R.; Gao, F.; Lassman, C.; Busuttil, R. W.; Cheng, G.; Kupiec-Weglinski, J. W. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173:7115-7119; 2004.
109. Bamboat, Z. M.; Balachandran, V. P.; Ocuin, L. M.; Obaid, H.; Plitas, G.; Dematteo, R. P. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51:621-632; 2009.
110. Zeng, S.; Feirt, N.; Goldstein, M.; Guarrera, J.; Ippagunta, N.; Ekong, U.; Dun, H.; Lu, Y.; Qu, W.; Schmidt, A. M.; Emond, J. C. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 39:422-432; 2004.
111. Lentsch, A. B.; Kato, A.; Yoshidome, H.; McMasters, K. M.; Edwards, M. J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32:169-173; 2000.
112. Clarke, C. N.; Kuboki, S.; Tevar, A.; Lentsch, A. B.; Edwards, M. CXC chemokines play a critical role in liver injury, recovery, and regeneration. Am. J. Surg. 198: 415-419; 2009.
113. Ding, W. X.; Yin, X. M. Dissection of the multiple mechanisms of TNF-α-induced apoptosis in liver injury. J. Cell. Mol. Med. 8:445-454; 2004.
114. Shen, X.; Wang, Y.; Gao, F.; Ren, F.; Busuttil, R. W.; Kupiec-Weglinski, J. W.; Zhai, Y. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 50:1537-1546; 2009.
115. Zhai, Y.; Shen, X. D.; Gao, F.; Zhao, A.; Freitas, M. C.; Lassman, C.; Luster, A. D.; Busuttil, R. W.; Kupiec-Weglinski, J. W. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 47:207-214; 2008.
116. Hanschen, M.; Zahler, S.; Krombach, F.; Khandoga, A. Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia-reperfusion. Transplantation 86:710-718; 2008.
117. Colletti, L. M.; Green, M. E.; Burdick, M. D.; Strieter, R. M. The ratio of ELR+ to ELR- CXC chemokines affects the lung and liver injury following hepatic ischemia/ reperfusion in the rat. Hepatology 31:435-445; 2000.
118. Babior, B. M.; Curnutte, J. T.; McMurrich, B. J. The particulate superoxide-forming system from human neutrophils: properties of the system and further evidence supporting its participation in the respiratory burst. J. Clin. Invest. 58:989-996; 1976.
119. Yui, Y.; Hattori, R.; Kosuga, K.; Eizawa, H.; Hiki, K.; Ohkawa, S.; Ohnishi, K.; Terao, S.; Kawai, C. Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils. J. Biol. Chem. 266:3369-3371; 1991.
120. Menger, M. D.; Vollmar, B. Role of microcirculation in transplantation. Microcirculation 7:291-306; 2000.
121. Thomas, S. R.; Witting, P. K.; Drummond, G. R. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 10:1713-1765; 2008.
122. Thomas, S. R.; Chen, K.; Keaney, J. F. Oxidative stress and endothelial nitric oxide bioactivity. Antioxid. Redox Signal. 5:181-194; 2003.
123. Halliwell, B. Phagocyte-derived reactive species: salvation or suicide? Trends Biochem. Sci. 31:509-515; 2006.
124. Fridovich, I. Superoxide dismutases: an adaptation to a paramagnetic gas. J. Biol. Chem. 264:7761-7764; 1989.
125. Fenton, H. J. H. LXXIII. Oxidation of tartaric acid in presence of iron. J. Chem. Soc. Trans. 65:899-910; 1894.
126. Rouault, T. A. How mammals acquire and distribute iron needed for oxygen-based metabolism. PLoS Biol. 1:E79; 2003.
127. Swain, J. A.; Darley-Usmar, V.; Gutteridge, J. M. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett. 342:49-52; 1994.
128. Prasad, M. R.; Engelman, R. M.; Jones, R. M.; Das, D. K. Effects of oxyradicals on oxymyoglobin: deoxygenation, haem removal and iron release. Biochem. J. 263:731-736; 1989.
129. Puppo, A.; Halliwell, B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron: is haemoglobin a biological Fenton reagent? Biochem. J. 249:185-190; 1988.
130. Gutteridge, J. M. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 201:291-295; 1986.
131. Biemond, P.; van Eijk, H. G.; Swaak, A. J.; Koster, J. F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: possible mechanism in inflammation diseases. J. Clin. Invest. 73:1576-1579; 1984.
132. Barbucci, R.; Magnani, A.; Lamponi, S.; Mitola, S.; Ziche, M.; Morbidelli, L.; Bussolino, F. Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative: effect on the motility of vascular endothelial cells. J. Inorg. Biochem. 81:229-237; 2000.
133. Klebanoff, S. J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77:598-625; 2005.
134. Collins, J. L.; Vodovotz, Y.; Hierholzer, C.; Villavicencio, R. T.; Liu, S.; Alber, S.; Gallo, D.; Stolz, D. B.; Watkins, S. C.; Godfrey, A.; Gooding, W.; Kelly, E.; Peitzman, A. B.; Billiar, T. R. Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock. Shock 19: 117-122; 2003.
135. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064; 1992.
136. Huie, R. E.; Padmaja, S. The reaction of NO with superoxide. Free. Radic. Res. Commun. 18:195-199; 1993.
137. Kissner, R.; Nauser, T.; Bugnon, P.; Lye, P. G.; Koppenol, W. H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem. Res. Toxicol. 10:1285-1292; 1997.
138. Radi, R.; Peluffo, G.; Alvarez, M. N.; Naviliat, M.; Cayota, A. Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30:463-488; 2001.
139. Crow, J. P.; Spruell, C.; Chen, J.; Gunn, C.; Ischiropoulos, H.; Tsai, M.; Smith, C. D.; Radi, R.; Koppenol, W. H.; Beckman, J. S. On the pH-dependent yield of hydroxyl radical products from peroxynitrite. Free Radic. Biol. Med. 16:331-338; 1994.
140. Denicola, A.; Freeman, B. A.; Trujillo, M.; Radi, R. Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations. Arch. Biochem. Biophys. 333:49-58; 1996.
141. Bonini, M. G.; Radi, R.; Ferrer-Sueta, G.; Ferreira, A. M.; Augusto, O. Direct EPR detection of the carbonate radical anion produced from peroxynitrite and carbon dioxide. J. Biol. Chem. 274:10802-10806; 1999.
142. Beckman, J. S.; Beckman, T. W.; Chen, J.; Marshall, P. A.; Freeman, B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87:1620-1624; 1990.
143. Augusto, O.; Bonini, M. G.; Amanso, A. M.; Linares, E.; Santos, C. C.; De Menezes, S. L. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic. Biol. Med. 32:841-859; 2002.
144. Pacher, P.; Beckman, J. S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87:315-424; 2007.
145. Armstrong, D. A.;Waltz, W. L.; Rauk, A. Carbonate radical anion-thermochemistry. Can. J. Chem. 84:1614-1619; 2006.
146. Corte, E. D.; Stirpe, F. The regulation of rat liver xanthine oxidase: involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem. J. 126: 739-745; 1972.
147. Harrison, R. Physiological roles of xanthine oxidoreductase. Drug Metab. Rev. 36: 363-375; 2004.
148. 2-dependent types of rat liver xanthine dehydrogenase. J. Biol. Chem. 264:10015-10022; 1989.
149. Frederiks, W. M.; Vreeling-Sindelárová, H. Ultrastructural localization of xanthine oxidoreductase activity in isolated rat liver cells. Acta Histochem. 104: 29-37; 2002.
150. Yamamoto, T.; Moriwaki, Y.; Takahashi, S.; Tsutsumi, Z.; Yamakita, J.; Nasako, Y.; Hiroishi, K.; Higashino, K. Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 681:395-400; 1996.
151. Pesonen, E. J.; Linder, N.; Raivio, K. O.; Sarnesto, A.; Lapatto, R.; Höckerstedt, K.; Mäkisalo, H.; Andersson, S. Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 114:1009-1015; 1998.
152. Weinbroum, A.; Nielsen, V. G.; Tan, S.; Gelman, S.; Matalon, S.; Skinner, K. A.; Bradley, E.; Parks, D. A. Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. Am. J. Physiol. 268:G988-G996; 1995.
153. Yokoyama, Y.; Beckman, J. S.; Beckman, T. K.; Wheat, J. K.; Cash, T. G.; Freeman, B. A.; Parks, D. A. Circulating xanthine oxidase: potential mediator of ischemic injury. Am. J. Physiol. 258:G564-G570; 1990.
154. Kooij, A.; Schiller, H. J.; Schijns, M.; Van Noorden, C. J.; Frederiks, W. M. Conversion of xanthine dehydrogenase into xanthine oxidase in rat liver and plasma at the onset of reperfusion after ischemia. Hepatology 19:1488-1495; 1994.
155. Radi, R.; Rubbo, H.; Bush, K.; Freeman, B. A. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes. Arch. Biochem. Biophys. 339:125-135; 1997.
156. Houston, M.; Estevez, A.; Chumley, P.; Aslan, M.; Marklund, S.; Parks, D. A.; Freeman, B. A. Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J. Biol. Chem. 274:4985-4994; 1999.
157. Adachi, T.; Fukushima, T.; Usami, Y.; Hirano, K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem. J. 289 (Pt 2):523-527; 1993.
158. Radi, R.; Bush, K. M.; Cosgrove, T. P.; Freeman, B. A. Reaction of xanthine oxidase-derived oxidants with lipid and protein of human plasma. Arch. Biochem. Biophys. 286:117-125; 1991.
159. Zhang, X.; Mosser, D. M. Macrophage activation by endogenous danger signals. J. Pathol. 214:161-178; 2008.
160. Mosser, D. M.; Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969; 2008.
161. Babior, B. M. The respiratory burst of phagocytes. J. Clin. Invest. 73:599-601; 1984.
162. -• release by activated Kupffer cells upon hypoxia-reoxygenation. Am. J. Physiol. 261:G602-G607; 1991.
163. Segal, A. W.; Garcia, R.; Goldstone, H.; Cross, A. R.; Jones, O. T. Cytochrome b-245 of neutrophils is also present in human monocytes, macrophages and eosinophils. Biochem. J. 196:363-367; 1981.
164. Cross, A. R.; Segal, A. W. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim. Biophys. Acta 1657:1-22; 2004.
165. Li, J. M.; Shah, A. M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277:19952-19960; 2002.
166. Bayraktutan, U.; Blayney, L.; Shah, A. M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20:1903-1911; 2000.
167. Van Buul, J. D.; Fernandez-Borja, M.; Anthony, E. C.; Hordijk, P. L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid. Redox Signal. 7:308-317; 2005.
168. Sorescu, D.; Weiss, D.; Lassègue, B.; Clempus, R. E.; Szöcs, K.; Sorescu, G. P.; Valppu, L.; Quinn, M. T.; Lambeth, J. D.; Vega, J. D.; Taylor, W. R.; Griendling, K. K. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 105:1429-1435; 2002.
169. Ago, T.; Kitazono, T.; Ooboshi, H.; Iyama, T.; Han, Y. H.; Takada, J.; Wakisaka, M.; Ibayashi, S.; Utsumi, H.; Iida, M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109:227-233; 2004.
170. Hiraishi, H.; Terano, A.; Razandi, M.; Pedram, A.; Sugimoto, T.; Harada, T.; Ivey, K. J. Reactive oxygen metabolite-induced toxicity to cultured bovine endothelial cells: status of cellular iron in mediating injury. J. Cell. Physiol. 160:132-134; 1994.
171. Jung, O.; Marklund, S. L.; Geiger, H.; Pedrazzini, T.; Busse, R.; Brandes, R. P. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ. Res. 93:622-629; 2003.
172. Bienert, G. P.; Møller, A. L.; Kristiansen, K. A.; Schulz, A.; Møller, I. M.; Schjoerring, J. K.; Jahn, T. P. Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem. 282:1183-1192; 2007.
173. Rees, M. D.; Hawkins, C. L.; Davies, M. J. Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J. Am. Chem. Soc. 125:13719-13733; 2003.
174. Rees, M. D.; Davies, M. J. Heparan sulfate degradation via reductive homolysis of its N-chloro derivatives. J. Am. Chem. Soc. 128:3085-3097; 2006.
175. Hecker, M.; Mülsch, A.; Bassenge, E.; Förstermann, U.; Busse, R. Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: physiological implications. Biochem. J. 299 (Pt 1):247-252; 1994.
176. Alderton, W. K.; Cooper, C. E.; Knowles, R. G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:593-615; 2001.
177. Stuehr, D. J.; Kwon, N. S.; Nathan, C. F.; Griffith, O. W.; Feldman, P. L.; Wiseman, J. Nω-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266:6259-6263; 1991.
178. Vásquez-Vivar, J.; Kalyanaraman, B.; Martásek, P.; Hogg, N.; Masters, B. S.; Karoui, H.; Tordo, P.; Pritchard, K. A. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U. S. A. 95: 9220-9225; 1998.
179. Hemmens, B.; Goessler, W.; Schmidt, K.; Mayer, B. Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase. J. Biol. Chem. 275:35786-35791; 2000.
180. Raman, C. S.; Li, H.; Martásek, P.; Král, V.; Masters, B. S.; Poulos, T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95:939-950; 1998.
181. Zou, M. H.; Shi, C.; Cohen, R. A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109:817-826; 2002.
182. Chalupsky, K.; Cai, H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 102:9056-9061; 2005.
183. Milstien, S.; Katusic, Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem. Biophys. Res. Commun. 263: 681-684; 1999.
184. Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6:173-182; 2006.
185. Henson, P. M. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J. Immunol. 107:1535-1546; 1971.
186. Harrison, J. E.; Schultz, J. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1371-1374; 1976.
187. Odajima, T.; Yamazaki, I. Myeloperoxidase of the leukocyte of normal blood. I. Reaction of myeloperoxidase with hydrogen peroxide. Biochim. Biophys. Acta 206:71-77; 1970.
188. Furtmüller, P. G.; Burner, U.; Obinger, C. Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. Biochemistry 37:17923-17930; 1998.
189. Segal, A.W. Howneutrophils kill microbes. Annu. Rev. Immunol. 23:197-223; 2005.
190. Winterbourn, C. C. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181-182:223-227; 2002.
191. Thomas, E. L.; Bozeman, P. M.; Jefferson, M. M.; King, C. C. Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase: formation of bromamines. J. Biol. Chem. 270:2906-2913; 1995.
192. Gaut, J. P.; Yeh, G. C.; Tran, H. D.; Byun, J.; Henderson, J. P.; Richter, G. M.; Brennan, M. L.; Lusis, A. J.; Belaaouaj, A.; Hotchkiss, R. S.; Heinecke, J. W. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci. U. S. A. 98: 11961-11966; 2001.
193. Khandoga, A.; Biberthaler, P.; Messmer, K.; Krombach, F. Platelet-endothelial cell interactions during hepatic ischemia-reperfusion in vivo: a systematic analysis. Microvasc. Res. 65:71-77; 2003.
194. Khandoga, A.; Kessler, J. S.; Meissner, H.; Hanschen, M.; Corada, M.; Motoike, T.; Enders, G.; Dejana, E.; Krombach, F. Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 106:725-733; 2005.
195. Khandoga, A.; Hanschen, M.; Kessler, J. S.; Krombach, F. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 43:306-315; 2006.
196. Sindram, D.; Porte, R. J.; Hoffman, M. R.; Bentley, R. C.; Clavien, P. A. Synergism between platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic rat liver: a Kupffer cell-mediated injury. FASEB J. 15:1230-1232; 2001.
197. Marcus, A. J.; Silk, S. T.; Safier, L. B.; Ullman, H. L. Superoxide production and reducing activity in human platelets. J. Clin. Invest. 59:149-158; 1977.
198. Finazzi-Agrò, A.; Menichelli, A.; Persiani, M.; Biancini, G.; Del Principe, D. Hydrogen peroxide release from human blood platelets. Biochim. Biophys. Acta 718: 21-25; 1982.
199. Pignatelli, P.; Sanguigni, V.; Lenti, L.; Ferro, D.; Finocchi, A.; Rossi, P.; Violi, F. gp91phox-dependent expression of platelet CD40 ligand. Circulation 110: 1326-1329; 2004.
200. Seno, T.; Inoue, N.; Gao, D.; Okuda, M.; Sumi, Y.; Matsui, K.; Yamada, S.; Hirata, K. -I.; Kawashima, S.; Tawa, R.; Imajoh-Ohmi, S.; Sakurai, H.; Yokoyama, M. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb. Res. 103:399-409; 2001.
201. O'Donnell, B. V.; Tew, D. G.; Jones, O. T.; England, P. J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290 (Pt 1):41-49; 1993.
202. Naseem, K. M.; Riba, R. Unresolved roles of platelet nitric oxide synthase. J. Thromb. Haemost. 6:10-19; 2008.
203. Naseem, K. M. eNOS, iNOS or no NOS, that is the question! J. Thromb. Haemost. 6: 1373-1375; 2008.
204. Leo, R.; Praticò, D.; Iuliano, L.; Pulcinelli, F. M.; Ghiselli, A.; Pignatelli, P.; Colavita, A. R.; FitzGerald, G. A.; Violi, F. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation 95:885-891; 1997.
205. Begonja, A. J.; Gambaryan, S.; Geiger, J.; Aktas, B.; Pozgajova, M.; Nieswandt, B.; Walter, U. Platelet NAD(P)H-oxidase-generated ROS production regulates αIIβ3-integrin activation independent of the NO/cGMP pathway. Blood 106: 2757-2760; 2005.
206. Krötz, F.; Sohn, H. Y.; Gloe, T.; Zahler, S.; Riexinger, T.; Schiele, T. M.; Becker, B. F.; Theisen, K.; Klauss, V.; Pohl, U. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100:917-924; 2002.
207. Massberg, S.; Enders, G.; Matos, F. C.; Tomic, L. I.; Leiderer, R.; Eisenmenger, S.; Messmer, K.; Krombach, F. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 94:3829-3838; 1999.
208. McCord, J. M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 185:529-531; 1974.
209. Raats, C. J.; Bakker, M. A.; van den Born, J.; Berden, J. H. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J. Biol. Chem. 272:26734-26741; 1997.
210. Moseley, R.; Waddington, R. J.; Embery, G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim. Biophys. Acta 1362:221-231; 1997.
211. Kennett, E. C.; Davies, M. J. Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: evidence for a hydroxyl-radical-like mechanism. Free Radic. Biol. Med. 42:1278-1289; 2007.
212. Al-Assaf, S.;Navaratnam, S.; Parsons, B. J.; Phillips, G. O. Chain scission of hyaluronan by peroxynitrite. Arch. Biochem. Biophys. 411:73-82; 2003.
213. Kennett, E. C.; Davies, M. J. Glycosaminoglycans are fragmented by hydroxyl, carbonate, and nitrogen dioxide radicals in a site-selective manner: implications for peroxynitrite-mediated damage at sites of inflammation. Free Radic. Biol. Med. 47:389-400; 2009.
214. Al-Assaf, S.; Navaratnam, S.; Parsons, B. J.; Phillips, G. O. Chain scission of hyaluronan by carbonate and dichloride radical anions: potential reactive oxidative species in inflammation? Free Radic. Biol. Med. 40:2018-2027; 2006.
215. McGowan, S. E. Mechanisms of extracellular matrix proteoglycan degradation by human neutrophils. Am. J. Respir. Cell Mol. Biol. 2:271-279; 1990.
216. Senthilmohan, R.; Kettle, A. J. Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. Arch. Biochem. Biophys. 445:235-244; 2006.
217. Rees, M. D.; McNiven, T. N.; Davies, M. J. Degradation of extracellular matrix and its components by hypobromous acid. Biochem. J. 401:587-596; 2007.
218. Hawkins, C. L.; Davies, M. J. The role of reactive N-bromo species and radical intermediates in hypobromous acid-induced protein oxidation. Free Radic. Biol. Med. 39:900-912; 2005.
219. Hawkins, C. L.; Davies, M. J. Degradation of hyaluronic acid, poly- and monosaccharides, and model compounds by hypochlorite: evidence for radical intermediates and fragmentation. Free Radic. Biol. Med. 24:1396-1410; 1998.
220. Ilan, Y.; Rabani, J. On some fundamental reactions in radiation chemistry: nanosecond pulse radiolysis. Int. J. Radiat. Phys. Chem. 8:609-611; 1976.
221. Rees, M. D.; Pattison, D. I.; Davies, M. J. Oxidation of heparan sulphate by hypochlorite: role of N-chloro derivatives and dichloramine-dependent fragmentation. Biochem. J. 391:125-134; 2005.
222. Neta, P.; Huie, R. E. Free-radical chemistry of sulfite. Environ. Health Perspect. 64: 209-217; 1985.
223. Ranguelova, K.; Mason, R. P. New insights into the detection of sulfur trioxide anion radical by spin trapping: radical trapping versus nucleophilic addition. Free Radic. Biol. Med. 47:128-134; 2009.
224. Kliment, C. R.; Englert, J. M.; Gochuico, B. R.; Yu, G.; Kaminski, N.; Rosas, I.; Oury, T. D. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J. Biol. Chem. 284:3537-3545; 2009.
225. Kliment, C. R.; Oury, T. D. Extracellular superoxide dismutase protects cardiovascular syndecan-1 from oxidative shedding. Free Radic. Biol. Med. 50:1075-1080; 2011.
226. Dolan, M.; Horchar, T.; Rigatti, B.; Hassell, J. R. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis. J. Biol. Chem. 272:4316-4322; 1997.
227. Kennett, E. C.; Davies, M. J. Degradation of extracellular matrix by peroxynitrite/peroxynitrous acid. Free Radic. Biol. Med. 45:716-725; 2008.
228. Kennett, E. C.; Rees, M. D.; Malle, E.; Hammer, A.; Whitelock, J. M.; Davies, M. J. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains. Free Radic. Biol. Med. 49:282-293; 2010.
229. Rees, M. D.; Whitelock, J. M.; Malle, E.; Chuang, C. Y.; Iozzo, R. V.; Nilasaroya, A.; Davies, M. J. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol. 29:63-73; 2010.
230. Rüdiger, H. A.; Clavien, P. A. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 122: 202-210; 2002.
231. Nieuwdorp, M.; Meuwese, M. C.; Mooij, H. L.; van Lieshout, M. H.; Hayden, A.; Levi, M.; Meijers, J. C.; Ince, C.; Kastelein, J. J.; Vink, H.; Stroes, E. S. Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202:296-303; 2009.
232. Chappell, D.; Hofmann-Kiefer, K.; Jacob, M.; Rehm, M.; Briegel, J.; Welsch, U.; Conzen, P.; Becker, B. F. TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res. Cardiol. 104: 78-89; 2009.
233. Henry, C. B.; Duling, B. R. TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 279:H2815-H2823; 2000.
234. Snoeijs, M. G.; Vink, H.; Voesten, N.; Christiaans, M. H.; Daemen, J. W.; Peppelenbosch, A. G.; Tordoir, J. H.; Peutz-Kootstra, C. J.; Buurman, W. A.; Schurink, G. W.; van Heurn, L. W. Acute ischemic injury to the renal microvasculature in human kidney transplantation. Am. J. Physiol. Ren. Physiol. 299: F1134-F1140; 2010.
235. Rehm, M.; Bruegger, D.; Christ, F.; Conzen, P.; Thiel, M.; Jacob, M.; Chappell, D.; Stoeckelhuber, M.; Welsch, U.; Reichart, B.; Peter, K.; Becker, B. F. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116:1896-1906; 2007.
236. Nelson, A.; Berkestedt, I.; Schmidtchen, A.; Ljunggren, L.; Bodelsson, M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 30:623-627; 2008.
237. Lentsch, A. B.; Yoshidome, H.; Kato, A.; Warner, R. L.; Cheadle, W. G.; Ward, P. A.; Edwards, M. J. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 30:1448-1453; 1999.
238. Spolarics, Z. Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid. J. Leukoc. Biol. 63:534-541; 1998.
239. Kurose, I.; Anderson, D. C.; Miyasaka, M.; Tamatani, T.; Paulson, J. C.; Todd, R. F.; Rusche, J. R.; Granger, D. N. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ. Res. 74:336-343; 1994.
240. Fattman, C. L.; Schaefer, L. M.; Oury, T. D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35:236-256; 2003.
241. Hecker, M.; Mülsch, A.; Bassenge, E.; Busse, R. Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am. J. Physiol. 265:H828-H833; 1993.
242. Varki, A.; Varki, A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 446:1023; 2007.
243. Schauer, R. Achievements and challenges of sialic acid research. Glycoconj. J. 17: 485-499; 2000.
244. Kumagai, R.; Lu, X.; Kassab, G. S. Role of glycocalyx in flow-induced production of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 47:600-607; 2009.
245. Ogasawara, Y.; Namai, T.; Yoshino, F.; Lee, M. C.; Ishii, K. Sialic acid is an essential moiety of mucin as a hydroxyl radical scavenger. FEBS Lett. 581:2473-2477; 2007.
246. Marklund, S. L. Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. U. S. A. 79:7634-7638; 1982.
247. Marklund, S. L. Extracellular superoxide dismutase in human tissues and human cell lines. J. Clin. Invest. 74:1398-1403; 1984.
248. Karlsson, K.; Lindahl, U.; Marklund, S. L. Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem. J. 256:29-33; 1988.
249. Kliment, C. R.; Tobolewski, J. M.; Manni, M. L.; Tan, R. J.; Enghild, J.; Oury, T. D. Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. Antioxid. Redox Signal. 10:261-268; 2008.
250. Gao, F.; Koenitzer, J. R.; Tobolewski, J. M.; Jiang, D.; Liang, J.; Noble, P. W.; Oury, T. D. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J. Biol. Chem. 283:6058-6066; 2008.
251. Wheeler, M. D.; Katuna, M.; Smutney, O. M.; Froh, M.; Dikalova, A.; Mason, R. P.; Samulski, R. J.; Thurman, R. G. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum. Gene Ther. 12:2167-2177; 2001.
252. He, S. Q.; Zhang, Y. H.; Venugopal, S. K.; Dicus, C. W.; Perez, R. V.; Ramsamooj, R.; Nantz, M. H.; Zern, M. A.; Wu, J. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl. 12: 1869-1879; 2006.
253. Varki, A. Sialic acids in human health and disease. Trends Mol. Med. 14:351-360; 2008.
254. Eguchi, H.; Ikeda, Y.; Ookawara, T.; Koyota, S.; Fujiwara, N.; Honke, K.; Wang, P. G.; Taniguchi, N.; Suzuki, K. Modification of oligosaccharides by reactive oxygen species decreases sialyl Lewis X-mediated cell adhesion. Glycobiology 15:1094-1101; 2005.
255. Nourshargh, S.; Hordijk, P. L.; Sixt, M. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 11: 366-378; 2010.
256. Ley, K.; Laudanna, C.; Cybulsky, M. I.; Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678-689; 2007.
257. Parks, W. C.; Wilson, C. L.; López-Boado, Y. S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4:617-629; 2004.
258. Viappiani, S.; Sariahmetoglu, M.; Schulz, R. The role of matrix metalloproteinase inhibitors in ischemia-reperfusion injury in the liver. Curr. Pharm. Des. 12: 2923-2934; 2006.
259. Liu, W.; Schöb, O.; Pugmire, J. E.; Jackson, D.; Zucker, K. A.; Fry, D. E.; Glew, R. H. Glycohydrolases as markers of hepatic ischemia-reperfusion injury and recovery. Hepatology 24:157-162; 1996.
260. Stöcker, W.; Grams, F.; Baumann, U.; Reinemer, P.; Gomis-Rüth, F. X.; McKay, D. B.; Bode, W. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4:823-840; 1995.
261. Van Wart, H. E.; Birkedal-Hansen, H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U. S. A. 87: 5578-5582; 1990.
262. Morgunova, E.; Tuuttila, A.; Bergmann, U.; Isupov, M.; Lindqvist, Y.; Schneider, G.; Tryggvason, K. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284:1667-1670; 1999.
263. Weiss, S. J.; Peppin, G.; Ortiz, X.; Ragsdale, C.; Test, S. T. Oxidative autoactivation of latent collagenase by human neutrophils. Science 227:747-749; 1985.
264. Rajagopalan, S.; Meng, X. P.; Ramasamy, S.; Harrison, D. G.; Galis, Z. S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J. Clin. Invest. 98:2572-2579; 1996.
265. Okamoto, T.; Akaike, T.; Nagano, T.; Miyajima, S.; Suga, M.; Ando, M.; Ichimori, K.; Maeda, H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342:261-274; 1997.
266. Fu, X.; Kassim, S. Y.; Parks, W. C.; Heinecke, J. W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276:41279-41287; 2001.
267. Gu, Z.; Kaul, M.; Yan, B.; Kridel, S. J.; Cui, J.; Strongin, A.; Smith, J. W.; Liddington, R. C.; Lipton, S. A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297:1186-1190; 2002.
268. Quijano, C.; Alvarez, B.; Gatti, R. M.; Augusto, O.; Radi, R. Pathways of peroxynitrite oxidation of thiol groups. Biochem. J. 322 (Pt 1):167-173; 1997.
269. Moon, K. H.; Hood, B. L.; Mukhopadhyay, P.; Rajesh, M.; Abdelmegeed, M. A.; Kwon, Y. I.; Conrads, T. P.; Veenstra, T. D.; Song, B. J.; Pacher, P. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 135:1344-1357; 2008.
270. Hernandez-Barrantes, S.; Toth, M.; Bernardo, M. M.; Yurkova, M.; Gervasi, D. C.; Raz, Y.; Sang, Q. A.; Fridman, R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 275:12080-12089; 2000.
271. Ra, H. J.; Parks, W. C. Control of matrix metalloproteinase catalytic activity. Matrix Biol. 26:587-596; 2007.
272. Carmeliet, P.; Moons, L.; Lijnen, R.; Baes, M.; Lemaître, V.; Tipping, P.; Drew, A.; Eeckhout, Y.; Shapiro, S.; Lupu, F.; Collen, D. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17: 439-444; 1997.
273. Kang, T.; Nagase, H.; Pei, D. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res. 62:675-681; 2002.
274. Brenner, D. A.; O'Hara, M.; Angel, P.; Chojkier, M.; Karin, M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-α. Nature 337:661-663; 1989.
275. Remacle, A. G.; Rozanov, D. V.; Fugere, M.; Day, R.; Strongin, A. Y. Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP. Oncogene 25:5648-5655; 2006.
276. Tellier, E.; Nègre-Salvayre, A.; Bocquet, B.; Itohara, S.; Hannun, Y. A.; Salvayre, R.; Augé, N. Role for furin in tumor necrosis factor α-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. Mol. Cell. Biol. 27: 2997-3007; 2007.
277. Cursio, R.; Mari, B.; Louis, K.; Rostagno, P.; Saint-Paul, M. C.; Giudicelli, J.; Bottero, V.; Anglard, P.; Yiotakis, A.; Dive, V.; Gugenheim, J.; Auberger, P. Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor. FASEB J. 16:93-95; 2002.
278. Knittel, T.; Mehde, M.; Kobold, D.; Saile, B.; Dinter, C.; Ramadori, G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1. J. Hepatol. 30:48-60; 1999.
279. Watanabe, T.; Niioka, M.; Ishikawa, A.; Hozawa, S.; Arai, M.; Maruyama, K.; Okada, A.; Okazaki, I. Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J. Hepatol. 35: 465-473; 2001.
280. Upadhya, A. G.; Harvey, R. P.; Howard, T. K.; Lowell, J. A.; Shenoy, S.; Strasberg, S. M. Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology 26:922-928; 1997.
281. Taraboletti, G.; D'Ascenzo, S.; Borsotti, P.; Giavazzi, R.; Pavan, A.; Dolo, V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 160:673-680; 2002.
282. Kjeldsen, L.; Sengeløv, H.; Lollike, K.; Nielsen, M. H.; Borregaard, N. Isolation and characterization of gelatinase granules from human neutrophils. Blood 83: 1640-1649; 1994.
283. Yu, W. H.; Woessner, J. F. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 275: 4183-4191; 2000.
284. Yu, Q.; Stamenkovic, I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13:35-48; 1999.
285. Brule, S.; Charnaux, N.; Sutton, A.; Ledoux, D.; Chaigneau, T.; Saffar, L.; Gattegno, L. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology 16:488-501; 2006.
286. Endo, K.; Takino, T.; Miyamori, H.; Kinsen, H.; Yoshizaki, T.; Furukawa, M.; Sato, H. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 278:40764-40770; 2003.
287. Kajita, M.; Itoh, Y.; Chiba, T.; Mori, H.; Okada, A.; Kinoh, H.; Seiki, M. Membranetype 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153:893-904; 2001.
288. Suenaga, N.; Mori, H.; Itoh, Y.; Seiki, M. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 24:859-868; 2005.
289. Mulivor, A. W.; Lipowsky, H. H. Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrix metalloprotease activity with doxycycline. Microcirculation 16:657-666; 2009.
290. Panaro, M. A.; Mitolo, V. Cellular responses to FMLP challenging: a mini-review. Immunopharmacol. Immunotoxicol. 21:397-419; 1999.
291. Hamada, T.; Fondevila, C.; Busuttil, R. W.; Coito, A. J. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology 47: 186-198; 2008.
292. Mainardi, C. L.; Dixit, S. N.; Kang, A. H. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J. Biol. Chem. 255:5435-5441; 1980.
293. Faurschou, M.; Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5:1317-1327; 2003.
294. Uchida, Y.; Freitas, M. C.; Zhao, D.; Busuttil, R. W.; Kupiec-Weglinski, J. W. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl. 15:939-947; 2009.
295. Uchida, Y.; Freitas, M. C.; Zhao, D.; Busuttil, R. W.; Kupiec-Weglinski, J. W. The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury. Transplantation 89:1050-1056; 2010.
296. Key, N. S.; Platt, J. L.; Vercellotti, G. M. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterioscler. Thromb. 12:836-842; 1992.
297. Buczek-Thomas, J. A.; Nugent, M. A. Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures: a mechanism for basic fibroblast growth factor (bFGF) release and attenuation of BFGF binding following elastase-induced injury. J. Biol. Chem. 274:25167-25172; 1999.
298. van de Lest, C. H.; Versteeg, E. M.; Veerkamp, J. H.; van Kuppevelt, T. H. Digestion of proteoglycans in porcine pancreatic elastase-induced emphysema in rats. Eur. Respir. J. 8:238-245; 1995.
299. Chung, M. C.; Jorgensen, S. C.; Popova, T. G.; Bailey, C. L.; Popov, S. G. Neutrophil elastase and syndecan shedding contribute to antithrombin depletion in murine anthrax. FEMS Immunol. Med. Microbiol. 54:309-318; 2008.
300. Campbell, E. J.; Owen, C. A. The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J. Biol. Chem. 282:14645-14654; 2007.
301. 2-chloride system. Am. J. Pathol. 143:907-917; 1993.
302. Gomis-Rüth, F. X.; Maskos, K.; Betz, M.; Bergner, A.; Huber, R.; Suzuki, K.; Yoshida, N.; Nagase, H.; Brew, K.; Bourenkov, G. P.; Bartunik, H.; Bode, W. Mechanism of inhibition of the humanmatrixmetalloproteinase stromelysin-1 by TIMP-1. Nature 389:77-81; 1997.
303. Brew, K.; Nagase, H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803:55-71; 2010.
304. Yu, W. H.; Yu, S.; Meng, Q.; Brew, K.; Woessner, J. F. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J. Biol. Chem. 275:31226-31232; 2000.
305. Beatty, K.; Bieth, J.; Travis, J. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J. Biol. Chem. 255:3931-3934; 1980.
306. Huntington, J. A.; Read, R. J.; Carrell, R. W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407:923-926; 2000.
307. Stavridi, E. S.; O'Malley, K.; Lukacs, C. M.; Moore, W. T.; Lambris, J. D.; Christianson, D. W.; Rubin, H.; Cooperman, B. S. Structural change in α-chymotrypsin induced by complexation with α1-antichymotrypsin as seen by enhanced sensitivity to proteolysis. Biochemistry 35:10608-10615; 1996.
308. Clark, R. A.; Stone, P. J.; El Hag, A.; Calore, J. D.; Franzblau, C. Myeloperoxidase-catalyzed inactivation of α1-protease inhibitor by human neutrophils. J. Biol. Chem. 256:3348-3353; 1981.
309. Taggart, C.; Cervantes-Laurean, D.; Kim, G.; McElvaney, N. G.; Wehr, N.; Moss, J.; Levine, R. L. Oxidation of either methionine 351 or methionine 358 in α1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275: 27258-27265; 2000.
310. Moreno, J. J.; Pryor, W. A. Inactivation of α1-proteinase inhibitor by peroxynitrite. Chem. Res. Toxicol. 5:425-431; 1992.
311. Taylor, K. R.; Trowbridge, J. M.; Rudisill, J. A.; Termeer, C. C.; Simon, J. C.; Gallo, R. L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279:17079-17084; 2004.
312. Horton, M. R.; McKee, C.M.; Bao, C.; Liao, F.; Farber, J.M.; Hodge-DuFour, J.; Puré, E.; Oliver, B. L.; Wright, T. M.; Noble, P. W. Hyaluronan fragments synergize with interferon-γ to induce the C-X-C chemokines MIG and interferon-inducible protein-10 in mouse macrophages. J. Biol. Chem. 273:35088-35094; 1998.
313. McKee, C. M.; Penno, M. B.; Cowman, M.; Burdick, M. D.; Strieter, R. M.; Bao, C.; Noble, P. W. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J. Clin. Invest. 98: 2403-2413; 1996.
314. Termeer, C. C.; Hennies, J.; Voith, U.; Ahrens, T.; Weiss, J. M.; Prehm, P.; Simon, J. C. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165:1863-1870; 2000.
315. Termeer, C.; Benedix, F.; Sleeman, J.; Fieber, C.; Voith, U.; Ahrens, T.; Miyake, K.; Freudenberg, M.; Galanos, C.; Simon, J. C. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195:99-111; 2002.
316. Saari, H. Oxygen derived free radicals and synovial fluid hyaluronate. Ann. Rheum. Dis. 50:389-392; 1991.
317. Scheibner, K. A.; Lutz, M. A.; Boodoo, S.; Fenton, M. J.; Powell, J. D.; Horton, M. R. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177:1272-1281; 2006.
318. Taylor, K. R.; Yamasaki, K.; Radek, K. A.; Di Nardo, A.; Goodarzi, H.; Golenbock, D.; Beutler, B.; Gallo, R. L. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282:18265-18275; 2007.
319. Yamasaki, K.; Muto, J.; Taylor, K. R.; Cogen, A. L.; Audish, D.; Bertin, J.; Grant, E. P.; Coyle, A. J.; Misaghi, A.; Hoffman, H. M.; Gallo, R. L. NLRP3/cryopyrin is necessary for interleukin-1β (IL-1β) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 284: 12762-12771; 2009.
320. Rockey, D. C.; Chung, J. J.;McKee, C.M.; Noble, P. W. Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 27:86-92; 1998.
321. Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-550; 2009.
322. Tschopp, J.; Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10: 210-215; 2010.
323. Johnson, G. B.; Brunn, G. J.; Kodaira, Y.; Platt, J. L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168:5233-5239; 2002.
324. Kodaira, Y.; Nair, S. K.; Wrenshall, L. E.; Gilboa, E.; Platt, J. L. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J. Immunol. 165:1599-1604; 2000.
325. Johnson, G. B.; Brunn, G. J.; Platt, J. L. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J. Immunol. 172:20-24; 2004.
326. Handel, T. M.; Johnson, Z.; Crown, S. E.; Lau, E. K.; Proudfoot, A. E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem. 74:385-410; 2005.
327. Lortat-Jacob, H.; Grosdidier, A.; Imberty, A. Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. U. S. A. 99: 1229-1234; 2002.
328. Li, Q.; Park, P. W.; Wilson, C. L.; Parks, W. C. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635-646; 2002.
329. Wang, L.; Fuster, M.; Sriramarao, P.; Esko, J. D. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6:902-910; 2005.
330. Bevilacqua, M. P.; Stengelin, S.; Gimbrone, M. A.; Seed, B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160-1165; 1989.
331. Parish, C. R. The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 6: 633-643; 2006.
332. Hayashida, K.; Parks, W. C.; Park, P. W. Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 114:3033-3043; 2009.
333. Constantinescu, A. A.; Vink, H.; Spaan, J. A. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler. Thromb. Vasc. Biol. 23:1541-1547; 2003.
334. Stocker, R.; Keaney, J. F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84:1381-1478; 2004.
335. Cai, H.; Harrison, D. G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87:840-844; 2000.